AHA Coding Clinic® for HCPCS - 2013 Quarter 2
RAC program highlights
In the first quarter 2013 issue of Coding Clinic for HCPCS newsletter, we addressed several coding issues that may be selected for RAC review. This follow-up article will provide further detail and clarification regarding several of the topics that are currently under review. Esophagogastroduodenoscopy A RAC review may be prompted for Esophagogastroduodenoscopy (CPT code range 43235 – 43259 ) procedures/services when the corresponding ICD-9-CM codes do not meet medical necessity. For assistance with this issue, review your local National Coverage Determination(s) and Local Coverage Determination(s), or contact your specific payor(s) for clarification. Bevacizumab (Avastin) services The units for HCPCS...
Subscribe or sign in to view the full article.
Article Overview
This article reviews several areas that may draw RAC attention and provides clarifying discussion for coding professionals working with HCPCS, CPT, and related coverage questions. It is aimed at facility and coding staff who need a broad understanding of the issues being highlighted, including procedure coding, drug unit reporting, modifier use, and add-on code reporting. The article also references payer coverage resources and the role of facility documentation in these scenarios.
Why This Topic Matters
RAC-related reviews can lead to payment issues when coding, unit reporting, or modifier reporting does not align with documentation or coverage expectations. This article helps readers understand which general topics are being emphasized so they can assess whether their workflows or claims may be affected.
Article Sections
-
Esophagogastroduodenoscopy
Discusses a procedure area under review and points readers to coverage resources and payer guidance. The focus is on understanding the general relevance of the topic to medical necessity review.
-
Bevacizumab (Avastin) services
Addresses reporting for a drug-related HCPCS service and the importance of unit-based billing conventions. The section is presented as clarification for claims that may be subject to review.
-
Modifier 74 (Discontinued outpatient procedure after anesthesia administration)
Covers modifier-related concerns in the outpatient setting and describes the general circumstances that prompt its discussion. The section frames the issue as a documentation and reporting topic.
-
Add-on codes without primary code
Explains a general compliance issue involving add-on procedure reporting and how such codes are identified in the CPT Manual. The section also includes an illustrative example of an add-on code relationship.
What You Will Learn
- Which broad RAC review topics are discussed in the article
- How the article frames coverage and medical necessity concerns
- What general issues are raised about unit-based drug reporting
- What topic is addressed regarding outpatient procedure discontinuation and modifier reporting
- How add-on procedure coding is discussed in relation to primary codes
Who Should Read This
- Medical coders
- Coding compliance staff
- Facility billing personnel
- Revenue integrity teams
- Healthcare reimbursement professionals
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.

Quick, Current, Complete - www.findacode.com